Common painkiller may hold key to stopping colon cancer before it starts
NCT ID NCT02965703
Summary
This study is testing whether taking aspirin daily or in on-and-off cycles can help prevent colorectal cancer in people who have precancerous growths called adenomas. Researchers are comparing three groups: daily aspirin, intermittent aspirin, and placebo, to see which schedule best changes markers in the gut that are linked to cancer development. The trial involves 81 adults and measures changes in rectal tissue samples over 12 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.